Literature DB >> 18840743

National seroprevalence and risk factors for Zoonotic Toxocara spp. infection.

Kimberly Y Won1, Deanna Kruszon-Moran, Peter M Schantz, Jeffrey L Jones.   

Abstract

To estimate the prevalence of Toxocara spp. infection in a representative sample of the United States population >or= 6 years of age, sera from participants in the Third National Health and Nutrition Examination Survey (1988-1994) were tested for antibodies to Toxocara. Among the 30,930 persons selected for the survey, 82% (N = 25,733) were interviewed, and 91% (N = 23,527) of those interviewed underwent physical examination of which 87% (N = 20,395) were tested. The age adjusted Toxocara seroprevalence was 13.9% (95% confidence intervals [CI] 12.5, 15.3), and was higher in non-Hispanic blacks (21.2%) than non-Hispanic whites (12%) or Mexican Americans (10.7%; P < 0.001). Increased Toxocara seropositivity was associated with head of household level of education (low versus high) (odds ratio [OR]: 2.2; CI: 1.8, 2.8), poverty (OR: 1.5; CI: 1.3, 1.8), elevated blood lead concentrations (OR: 1.4; CI: 1.1, 1.9), and dog ownership (OR: 1.2; CI: 1.1, 1.4). Toxocara infection is widespread and associated with specific risk groups.

Entities:  

Mesh:

Year:  2008        PMID: 18840743

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  70 in total

1.  Toxocara infection in the United States: the relevance of poverty, geography and demography as risk factors, and implications for estimating county prevalence.

Authors:  Peter Congdon; Patsy Lloyd
Journal:  Int J Public Health       Date:  2010-04-27       Impact factor: 3.380

2.  Recombinant antigen-based enzyme-linked immunosorbent assay for diagnosis of Baylisascaris procyonis larva migrans.

Authors:  Sriveny Dangoudoubiyam; Ramesh Vemulapalli; Momar Ndao; Kevin R Kazacos
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

3.  Cough syncope and multiple pulmonary nodules.

Authors:  Louis Kreitmann; François Collet; Jean-Paul Gouello; Malcolm Lemyze
Journal:  Intern Emerg Med       Date:  2011-02-13       Impact factor: 3.397

4.  Toxocariasis presenting as eosinophilic ascites in a post-partum female.

Authors:  Malini Guha; Sunit Jariwala; Nana Jinjolova; Nicole Mazer; Elizabeth Revere; Paul Riska; Elina Jerschow
Journal:  J Parasit Dis       Date:  2013-07-09

5.  Anti-Toxocara spp. antibodies in an adult healthy population: serosurvey and risk factors in Southeast Brazil.

Authors:  Elaine Cristina Negri; Vamilton Alvares Santarém; Guita Rubinsky-Elefant; Rogério Giuffrida
Journal:  Asian Pac J Trop Biomed       Date:  2013-03

6.  People, pets, and parasites: one health surveillance in southeastern Saskatchewan.

Authors:  Janna M Schurer; Momar Ndao; Helen Quewezance; Stacey A Elmore; Emily J Jenkins
Journal:  Am J Trop Med Hyg       Date:  2014-03-17       Impact factor: 2.345

7.  Viral and parasitic pathogen burden and the association with stroke in a population-based cohort.

Authors:  Brad D Pearce; Anna Bracher; Jeffrey L Jones; Deanna Kruszon-Moran
Journal:  Int J Stroke       Date:  2017-09-15       Impact factor: 5.266

8.  Assessment of U.S. Pediatrician Knowledge of Toxocariasis.

Authors:  Dana M Woodhall; Amanda P Garcia; Craig A Shapiro; Shequenta L Wray; Andi L Shane; Chitra S Mani; Kelly K Stimpert; LeAnne M Fox; Susan P Montgomery
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

9.  Enteroparasitoses and Toxocarosis Affecting Children from Mar del Plata City, Argentina.

Authors:  Carla Lavallén; Beatriz Brignani; Karina Riesgo; Amalia Rojas; Gabriela Colace; Martín Biscaychipi; Estela Chicote; Cristian Giuntini; Mariela Kifer; María Eugenia Del Río; Guillermo Denegri; Marcela Dopchiz
Journal:  Ecohealth       Date:  2017-04-21       Impact factor: 3.184

10.  Toxoplasmosis and Toxocariasis: An Assessment of Human Immunodeficiency Virus Comorbidity and Health-Care Costs in Canada.

Authors:  Janna M Schurer; Ellen Rafferty; Michael Schwandt; Wu Zeng; Marwa Farag; Emily J Jenkins
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.